Vaccinex
Patents, Design & Utilities

Last updated:

List of all Vaccinex patents 32 in total

Status Patent
Application
Utility: ANTI-CD100 ANTIBODIES AND METHODS FOR USING THE SAME External link
Filling date: 26 Sep 2025 Issue date: 16 Jun 2022
Grant
Utility: Anti-CD100 antibodies and methods for using the same External link
Filling date: 26 Sep 2025 Issue date: 15 Mar 2022
Application
Utility: USE OF SEMAPHORIN-4D BINDING MOLECULES FOR THE TREATMENT OF RETT SYNDROME External link
Filling date: 26 Sep 2025 Issue date: 30 Dec 2021
Application
Utility: USE OF CXCL13 BINDING MOLECULES TO PROMOTE PERIPHERAL NERVE REGENERATION External link
Filling date: 26 Sep 2025 Issue date: 16 Dec 2021
Application
Utility: INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS External link
Filling date: 26 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: USE OF SEMAPHORIN-4D INHIBITORY MOLECULES WITH AN IMMUNE MODULATING THERAPY TO INHIBIT TUMOR GROWTH AND METASTASES External link
Filling date: 26 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: ANTI-CCR8 ANTIBODIES AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 5 Aug 2021
Grant
Utility: Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases External link
Filling date: 26 Sep 2025 Issue date: 3 Aug 2021
Application
Utility: TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WITH AN EPIGENETIC MODULATING AGENT External link
Filling date: 26 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME External link
Filling date: 26 Sep 2025 Issue date: 25 Mar 2021
Application
Utility: COMBINED INHIBITION OF SEMAPHORIN-4D AND TGF-BETA AND COMPOSITIONS THEREFOR External link
Filling date: 26 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: HUMAN ANTI-SEMAPHORIN 4D ANTIBODY External link
Filling date: 26 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE (SEMA4D) AND DC1 THERAPY External link
Filling date: 26 Sep 2025 Issue date: 24 Dec 2020
Grant
Utility: Integral membrane protein display on poxvirus extracellular enveloped virions External link
Filling date: 26 Sep 2025 Issue date: 22 Dec 2020
Grant
Utility: Polynucleotides encoding anti-CXCL13 antibodies External link
Filling date: 26 Sep 2025 Issue date: 10 Nov 2020
Grant
Utility: Use of semaphorin-4D binding molecules for treating neurodegenerative disorders External link
Filling date: 26 Sep 2025 Issue date: 13 Oct 2020
Application
Utility: SEMAPHORIN-4D ANTAGONISTS FOR USE IN CANCER THERAPY External link
Filling date: 26 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA VIRUS/EUKARYOTIC CELLS External link
Filling date: 26 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: INTEGRAL MEMBRANE PROTIEN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS External link
Filling date: 26 Sep 2025 Issue date: 9 Jul 2020
Grant
Utility: Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunit External link
Filling date: 26 Sep 2025 Issue date: 26 May 2020
Grant
Utility: Methods for producing polynucleotide libraries in vaccinia virus/eukaryotic cells External link
Filling date: 26 Sep 2025 Issue date: 5 May 2020
Grant
Utility: Integral membrane protein display on poxvirus extracellular enveloped virions External link
Filling date: 26 Sep 2025 Issue date: 3 Mar 2020
Grant
Utility: Integral membrane protein display on poxvirus extracellular enveloped virions External link
Filling date: 26 Sep 2025 Issue date: 4 Feb 2020
Grant
Utility: Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases External link
Filling date: 26 Sep 2025 Issue date: 7 Jan 2020
Application
Utility: EARLY DETECTION OF GLIAL CELL ACTIVATION IN NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES External link
Filling date: 26 Sep 2025 Issue date: 19 Dec 2019
Grant
Utility: Use of semaphorin-4D binding molecules to promote neurogenesis following stroke External link
Filling date: 26 Sep 2025 Issue date: 3 Dec 2019
Application
Utility: USE OF SEMAPHORIN-4D BINDING MOLECULES FOR MODULATION OF BLOOD BRAIN BARRIER PERMEABILITY External link
Filling date: 26 Sep 2025 Issue date: 28 Nov 2019
Application
Utility: USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS External link
Filling date: 26 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS External link
Filling date: 26 Sep 2025 Issue date: 12 Sep 2019
Grant
Utility: Use of semaphorin-4D binding molecules for treating neurodegenerative disorders External link
Filling date: 26 Sep 2025 Issue date: 20 Aug 2019
Application
Utility: USE OF ANTI-SEMAPHORIN-4D ANTIBODIES MOLECULES WITH AN IMMUNE MODULATING THERAPY TO INHIBIT TUMOR GROWTH AND METASTASES External link
Filling date: 26 Sep 2025 Issue date: 15 Aug 2019
Application
Utility: METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA VIRUS/EUKARYOTIC CELLS External link
Filling date: 26 Sep 2025 Issue date: 8 Aug 2019

Showing 1 to 32 of 32 patents.